Select Medical's Rally Faces Scrutiny: Three Red Flags and a Preferred Alternative
Despite Select Medical's shares outperforming the S&P 500 by 15.8% over the past six months, a closer look reveals concerning trends in patient admissions, profitability, and capital returns that warrant investor caution.